Member Info for EmeraldCarrots

Bobat123

"There is also a distressed seller offloading for the past few days . Hopefully should be TR1 soon. That is what is also holding this back".

Do you have a crystal ball, or do you look at the tea leaves? Total guess based on Jack. In other words complete rubbish.

It's becoming obvious that some of the biggest Pharma Co's in the entire World have realised that the analysis of circulating tumour cells (CTC's) will play a major part of cancer research and treatment. The other massive pharma Co's that no doubt Angle are talking to need to get moving now as Angle are a relatively small Company and so will have to prioritise the workload. Developing these specialist assays is clearly very complex and time consuming. In several months’ time the turnaround time will be a lot lot longer I suspect. Fantastic news for Angle Plc!

Https://www.youtube.com/watch?v=TPvD_nmu4W8

Https://www.youtube.com/watch?v=TPvD_nmu4W8

Presentation. The commercial phase part of the presentation. "and I am hopeful we will be able to sign some other very large household name pharma Companies". Has delivered with Eisai Inc. and now Astrazeneca for starters. Obviously is talking to many others..... I suspect in the next 6 months we will have several "household name" Co's on the books.

https://www.youtube.com/watch?v=cnQ6M05BiBY

3.57% up now.

Up 1.79%.

Bantham.

EC - i have a bad feeling about this…..

============================

The idea is you buy LOW and then sell HIGH.

It seems to me the sp is low now...............

LOL!

Bantham.

Very negative you are.

Just bought 10k @ 14.295p.

We know they are having business dealings with both Astrazenica and Eisai Inc.

And they talk to Illumina and Thermo Fisher regularly.

More contracts to come............. it's obvious!

Buyers coming out of the woodwork now..................

Up and down like a yo-yo.

Just make sure you can hold for a while when you buy, just in case! LOL!

No-one knows for sure until the results are out.

The Parsortix machine costs as I understand it $60,000 to $70,000 depending on what model. That is quite a wad.

On 4th Jan Angle announced the "Breakthrough clinical results".

This revelation was this "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample highlights potential for the Parsortix system to identify key variants (DNA mutations) ****missed by other approaches**** to help guide treatment decisions". That means it would be in Illumina and Thermo Fishers interests to promote catching and analysing circulating tumour cells. Catching CTC's is what the Parsortix machine does.

So sales of said machines could be a lot better than people think.

Potentially there could be a deal with Illumina, or Thermo fisher to sell the Parsortix machine along side their kit.

Or the machine could be re-badged "Illumina" for instance and sold as an add on.

https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html

Loads of possibilities here.

All IMHO.

Any takers?

Adw198.

"Love how EC has dumped some of his but continue to spam us".

===================================

So I sold some @ 17p a share, so what! I was in too deep.

As for spamming. I've only been posting here. The likes of TwoGood2Die post on more than 1 site.

Also, I usually refer to the official RNS's. I don't just post complete rubbish and lies like some do on here.

If you can't see that most if not all the large pharma Co's conducting cancer drug trials involving metastasized cancers are highly likely to want this "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample" then I feel sorry for you. Anything that can be measurably affected as a result of a cancer treatment obviously needs measuring. It goes without saying. Totally and utterly obvious!

All IMHO.

The information when a cancer has metastasized (spread). What proof do we have that CTC's need to be examined?

1. Eisai Inc. RNS dated 2nd Jan 2024.

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

2. Astrazeneca announcement dated 24th April 2024.

https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-astrazeneca-edeymgqdtcshqde.html

3. Angle Plc announcement dated 4th Jan 2024 "Breakthrough clinical results".

https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html

Waiting the takeover bid!

All IMHO.

I don't think it will be long before they get more contracts from both them AND other massive Plc's in the World. People should not forget that Angle Plc can do business with almost any Company anywhere in the entire WORLD. The World is a big place is it not! As I have said the RNS of 4th Jan "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample" I think is going to make Angle Millions. In demonstrating circulating tumour cells (CTC's) when analysed give additional, valuable information over and above that routinely obtained via the standard CtDNA analysis HAS GOT TO GET MORE CONTRACTS. We now know standard CtDNA analysis offered by the likes of Illumina and Thermo Fisher do NOT obtain all the information available about the cancer's status. This makes "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample" simply a MUST HAVE................ and Angle offer this service ALREADY. This is going to be TRANSFORMATIONAL for Angle IMHO. Any Company starting a cancer drug trial involving ANY CANCER that has metastasized WILL WANT THIS ADDITIONL INFORMATION. A COMPLETE *****NO BRAINER*****.

I suspect Angle will get overwhelmed with orders........... really.

All IMHO.

The significance of the announcement on 4th Jan simply *****will NOT be ignored***** by the industry.

Let's assume your Company wants to carry out a drug trial using your Companies new promising cancer drug.

The drug is for use sometimes after the cancer has spread (metastasized). That means circulating tumour cells (CTC's) are present in the blood. Angles's Parsortix machine can "catch" these cells intact and indeed 99% of the time are STILL ALIVE for analysis. Angle Plc's RNS of 4th Jan has found that when comparing the CtDna results (of DNA fragments in blood) to exactly the same analysis of ***circulating tumour cells (CTC's)*** there are remarkable unexpected differences giving further clues as to the status of the cancer during treatment. Do you:-

A) Want to obtain this information during your very expensive drug trial to find out this information.

B) Ignore this additional expense to get the additional information and pray it is not that important because if it is your Company will have lost the opportunity and indeed you might get sacked for being totally incompetent.

https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html

All IMHO.

About to go positive I fear!

15p/16p now.

LOL!!!!

To me there are 3 things that are really important here. First and second we know they are talking to both Eisai In. (a top 100 Japanese Company AND now Astrazeneca (Top 100 UK Plc). Then to me the announcement of 4th January. Why? Because ANY Company doing a drug trial involving a metastasized cancer SIMPLY MUST AS THAT RNS says carry out "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample". See:-

https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html

Failure to do an analysis on both the CtDNA and CTC's (Circulating tumour cells) after AGL's RNS explaining the additional important information they found is NOT AN OPTION. It would be a complete *****dereliction of duty!*****

When the first contract lands for this service the £1.60 spike on FDA approval might again be reached!!!!

All IMHO.

Barno61

"A solid broker rating of 70p which sounds sensible and achievable.".

==============================

I have hardly ever called a brokers "sp target" low.

IMHO 70p now is, ebnen with the sp @ 15.5p.

Illumina, or Thermo Fisher, or another Company *** IN THE ENTIRE WORLD *** is going to realise they need live, intact circulating tumour cells to test............................................ as have EISAI INC. (top 100 Japanese Co. and now AstraZeneca) then IMHO that is LOW. The Parsortix device delivers (99% of the time) "Live" intact circulating tumour cells to test.........................................SIMPLES!!!

And the sp is not even back to 18p. BEYOND ridiculous IMHO!!!!!!!!

All IMHO.